Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets

NCT03420534 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Iloperidone 1 MG
DRUG: Placebo
DIETARY_SUPPLEMENT: fasting
DIETARY_SUPPLEMENT: postprandial

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.